In this article, we will take a look at some of the small-cap drug manufacturing stocks that are highly favored by hedge funds. On February 16, Franklin Templeton shared its outlook on the ...

CorMedix CRMD and Puma Biotechnology PBYI are small-cap biotech companies focused on the successful commercialization of their core products as they work to establish leadership within their ...

While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...

Small caps continue to have attractive valuations heading into 2026. Compared to large caps on a relative basis, small caps are significantly cheaper today than they were in most time periods. It is ...

Sun, December 14, 2025 at 4:58 PM UTC As the AI trade gets overheated and calls for some sort of bursting of the AI bubble grow louder, it might make sense to look to opportunities to be had within ...

The green shoots suggesting a comeback was in sight for biotech stocks last year have mostly grown into proverbial flowering plants—but one company’s precipitous year-over-year decline in market ...

Small caps are set to open into a mixed but opportunity-rich session, with ASX futures edging higher despite a fragile global ...